Bio + Health

Hey Tech, It’s Time To Build. In Healthcare.

Daisy Wolf and Vijay Pande Posted April 20, 2023

In the past few months, the founders of Instacart, Spotify, and Coinbase have all started new healthcare companies. This may seem odd to some–why are these seasoned tech founders jumping into tech-driven healthcare?

In 2013, Marc Andreessen observed that the biggest, most successful companies have all done something that seemed completely “crazy” at the time of creation. The examples from the last two decades are clear. Sleeping in a stranger’s home? Airbnb. Getting in a stranger’s car? Lyft. Putting a personal computer in everyone’s home, and then in everyone’s pocket, and then on everyone’s wrist? Apple.

But what sounds crazy in 2023? Certainly not another meal delivery service, recruiting tool, or dating app. More broadly, we all agree that mobile, internet, the cloud, and SaaS are consensus and mainstream.

Here’s what sounds crazy in 2023: Trying to fix the United States’ gigantic mess of a healthcare system.

The U.S.’s largest industry–one fifth of the American economy–is unspeakably broken. The United States severely lags behind other developed nations in terms of health outcomes and cost. Hundreds of thousands of people die each year because of avoidable human errors.

Modern technology has little penetration in healthcare. The industry still largely relies on paper and fax machines for communication.

The most impactful companies are built at the frontier, and healthcare is the next frontier. It’s time to put our tech skills to work. The mother of all markets is ripe for disruption.

The most impactful companies are built at the frontier, and healthcare is the next frontier. It’s time to put our tech skills to work. The mother of all markets is ripe for disruption.

“But….healthcare is hard.”

We hear you. Healthcare IS hard. It’s intimidating. It’s regulated. It’s complex. And that’s why it’s so exciting.

Let us address those three concerns head on.

First, healthcare is undoubtedly intimidating. But we’ve learned it, and so can you.

The overwhelming nature of healthcare largely can be attributed to the size of the market. It’s unfathomably large–$4 trillion in the US alone–and made up of countless submarkets.

But of course, the massive scale of the market is a good thing. The United States healthcare market is five times the size of the global advertising market in which the majority of the major tech companies operate. The American healthcare market could support dozens of FAANG (Facebook, Amazon, Apple, Netflix, Google)-scale companies, but today only one exists (UnitedHealth Group).

Second, we turn to the concern that healthcare is a highly regulated industry. This is indeed true, but many of the most iconic companies of our time–Lyft, Airbnb–have been built in complex, regulated markets. Furthermore, those that were built in unregulated markets–Google, Meta, Amazon–have all come to face intense regulatory scrutiny and pressure eventually. Regulation seems to be either an input to or a result of all great companies.

Like Lyft and Airbnb, healthcare faces national and state/local regulation. There is a federal system, with each state having its own medical board and insurance regulation. While this certainly is a source of opportunity, it also provides excellent grounds for experimentation, allowing a company to test different approaches in different geographies.

And the positive flip side of the government’s regulation is the government’s dollars. The federal and state governments spend over a trillion dollars on healthcare each year through programs like Medicare and Medicaid. This provides healthcare companies with very large, entrenched customers who never go away. Anyone who works in politics will tell you Medicare is untouchable for cost-cutting–seniors (the most reliable voters!) would revolt.

Third, and finally, we agree that healthcare is complex. But so are most markets–whether it’s the hotel industry, taxi industry, or the digital advertising industry. What makes healthcare feel even more complex is its scale, which we’ve established is a good thing. There are a wide variety of entities in healthcare (providers, payors, pharma, etc) which contribute to its complexity, but this is to be expected in any industry of this scale. Plus, complexity has benefits like defensibility–simple markets and solutions have way more competitors and copycats and lend themselves to commoditization.

Why you should come to healthcare

The above concerns can be summarized as “healthcare is scary.” We believe scary is where the opportunity lies. So here’s why you should bring your tech skills to healthcare.

To start, healthcare needs tech. While the PhDs developing novel cancer drugs and diagnostics are incredibly important, they are just a tiny part of this market. Even if we cure all cancer, Americans’ lifespan would just increase by three years. Instead, some of the biggest problems in healthcare are going to be solved by technology. Healthcare at its core is (1) a data, operations, and logistics problem, and (2) a consumer experience and engagement problem. Both are areas where the tech world excels.

When it comes to data, operations, and logistics, the current state of healthcare leaves endless opportunity for improvement. $765 billion is wasted annually, with the main driver being human administrative overhead. There still isn’t true data interoperability–one person’s important medical records lay across dozens of different doctor’s offices and health systems with little hope of being pieced together. Most promising drugs will never go through clinical trials and become accessible to patients because we still haven’t figured out how to recruit trial participants and run studies in a cost-effective manner. None of these problems require an MD or a PhD to solve, and each is a multibillion dollar opportunity.

When it comes to consumer engagement, we’ve written before about how poor consumer engagement, caused by poor consumer experience, is one of the biggest problems in healthcare. Most poor health outcomes and deaths are caused by diseases that we know how to prevent or cure. What’s needed in these scenarios is not more science. In addition to cultural change and policy change, what’s needed is people who can build better experiences to engage patients in their health–whether it’s eating healthier, exercising, going to the doctor, or taking their medication. No one is better suited to solve these problems than the technologists who have excelled at consumer engagement in tech.

Moreover, healthcare provides the best opportunity out there to use the hottest tools in tech–especially AI–to displace huge incumbents. As we’ve written about recently, deploying AI in traditional tech software businesses presents a number of challenges, namely that AI has lower gross margins than SaaS due to heavy cloud infrastructure usage and ongoing human support.

In healthcare, this situation is the opposite. Most of the healthcare industry is services, which have low gross margins. In healthcare, AI stands to dramatically improve the previously unpleasant economics, making building in the industry far more compelling. Furthermore, human-driven services tend to scale linearly with each incremental human added, but AI-driven services can scale exponentially.

And while margins are nice, mission is nicer. When you think about the limited number of days you have on this planet and the insane number of hours you’ll pour into building a startup, wouldn’t it be great if you were working on something that really mattered? You don’t have to be a doctor or cancer researcher to save lives. A company detecting medical errors or helping people afford medical care might save countless lives.

Even if this isn’t a motivator for you personally, the mission orientation of healthcare will help you attract better talent that you’d get in other industries. Eighty percent of college graduates say that it is very or extremely important to derive a sense of purpose from their work. Millennials prioritize purpose in their lives even more than older generations, and they look to work more than other sources to find it.

Working to improve healthcare is an obvious way to find purpose in one’s work–basically every American can relate on a personal level to how broken the American healthcare system is. Who hasn’t been asked to fill out endless pages of paper medical forms for the fifty-seventh time, received a large and unexpected medical bill, or lost a loved one to preventable or treatable disease?

In addition, the mission orientation of healthcare can likely help your talent perform better. Gallup reports “there is a strong correlation between employees’ purpose and engagement and organizations bottom line.” McKinsey finds that “people who live their purpose at work are more productive than people who don’t. They are also healthier, more resilient, and more likely to stay at the company.”

Finally, we think your tech mindset can be a huge asset in leading a healthcare company. Of course, tech founders building in healthcare must learn healthcare on a deep level, and we recommend surrounding yourself with healthcare veterans to do so (this is especially true in the ideation phase). But the advantages of coming from tech are clear. Tech moves faster than healthcare. The tech world produces visionaries who don’t accept that the ways things work today will be the way things work in the future. Your fresh eyes are exactly what healthcare needs.

Trying to fix healthcare in 2023 sounds crazy and is certainly non-consensus. But in what other industry could you build the biggest company in the world?

Want More a16z Bio + Health?

Insights, analysis, and additional reading on bio and health, and how both are shaping our future.

Learn More

Want More Bio+Health?

Insights, analysis, and additional reading on bio and health, and how both are shaping our future.

Sign Up On Substack

Views expressed in “posts” (including podcasts, videos, and social media) are those of the individual a16z personnel quoted therein and are not the views of a16z Capital Management, L.L.C. (“a16z”) or its respective affiliates. a16z Capital Management is an investment adviser registered with the Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. The posts are not directed to any investors or potential investors, and do not constitute an offer to sell — or a solicitation of an offer to buy — any securities, and may not be used or relied upon in evaluating the merits of any investment.

The contents in here — and available on any associated distribution platforms and any public a16z online social media accounts, platforms, and sites (collectively, “content distribution outlets”) — should not be construed as or relied upon in any manner as investment, legal, tax, or other advice. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment. Any projections, estimates, forecasts, targets, prospects and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any charts provided here or on a16z content distribution outlets are for informational purposes only, and should not be relied upon when making any investment decision. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, posts may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. All content speaks only as of the date indicated.

Under no circumstances should any posts or other information provided on this website — or on associated content distribution outlets — be construed as an offer soliciting the purchase or sale of any security or interest in any pooled investment vehicle sponsored, discussed, or mentioned by a16z personnel. Nor should it be construed as an offer to provide investment advisory services; an offer to invest in an a16z-managed pooled investment vehicle will be made separately and only by means of the confidential offering documents of the specific pooled investment vehicles — which should be read in their entirety, and only to those who, among other requirements, meet certain qualifications under federal securities laws. Such investors, defined as accredited investors and qualified purchasers, are generally deemed capable of evaluating the merits and risks of prospective investments and financial matters.

There can be no assurances that a16z’s investment objectives will be achieved or investment strategies will be successful. Any investment in a vehicle managed by a16z involves a high degree of risk including the risk that the entire amount invested is lost. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by a16z is available here: https://a16z.com/investments/. Past results of a16z’s investments, pooled investment vehicles, or investment strategies are not necessarily indicative of future results. Excluded from this list are investments (and certain publicly traded cryptocurrencies/ digital assets) for which the issuer has not provided permission for a16z to disclose publicly. As for its investments in any cryptocurrency or token project, a16z is acting in its own financial interest, not necessarily in the interests of other token holders. a16z has no special role in any of these projects or power over their management. a16z does not undertake to continue to have any involvement in these projects other than as an investor and token holder, and other token holders should not expect that it will or rely on it to have any particular involvement.

With respect to funds managed by a16z that are registered in Japan, a16z will provide to any member of the Japanese public a copy of such documents as are required to be made publicly available pursuant to Article 63 of the Financial Instruments and Exchange Act of Japan. Please contact compliance@a16z.com to request such documents.

For other site terms of use, please go here. Additional important information about a16z, including our Form ADV Part 2A Brochure, is available at the SEC’s website: http://www.adviserinfo.sec.gov.